Search

everythinglearnresearchcommunity

for

Search:↓

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.